Influence of the TNF-α and TNF-β polymorphisms upon infectious risk and outcome in surgical intensive care patients

Surgical Infections

Volumn 4, Issue 2, 2003, Pages 163-169

  Calvano, Jacqueline E ^a   Um, John Y ^a   Agnese, Doreen M ^a   Hahm, Sae J ^a   Kumar, Ashwini ^a   Coyle, Susette M ^a   Calvano, Steve E ^a   Lowry, Stephen F ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROFORM; DNA FRAGMENT; GENOMIC DNA; LYMPHOTOXIN; PHENOL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DNA ISOLATION; DNA POLYMORPHISM; FEMALE; GEL ELECTROPHORESIS; GENE SEQUENCE; GENOTYPE; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; SEPSIS; SEPTIC SHOCK; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL PATIENT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 0042921428     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/109629603766956951     Document Type: Article

References (23)

1. Sorensen TI, Nielsen GG, Andersen PK, et al. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988;318:727-732.
2. Debets JM, Kampmeijer R, Van der Linden M, et al. Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 1989;17: 489-494.
3. Dofferhoff AS, Bom VJ, De Vries-Hospers HG, et al. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans. Crit Care Med 1992;20:185-192.
4. α promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999;282:561-568.
5. O'Keefe GE, Hybki DL, Munford RS. The G-A single nucleotide polymorphism at the-308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma. J Trauma 2002; 52:817-825.
6. Stuber F, Petersen M, Bokelmann F, et al. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit Care Med 1996;24:381-384.
7. Tang GJ, Huang SL, Yien HW, et al. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 2000;28:2733-2736.
8. Majetschak M, Sascha F, Obertacke U, et al. Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 1999;230:207-214.
9. Van der Poll T, Lowry SF. Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense. Shock 1995;3:1-12.
10. Rogy MA, Oldenburn HAS, Calvano SE, et al. The role of bactericidal/permeability-increasing protein in the treatment of primate bacteremia and septic shock. J Clin Immunol 1994;14:120-133.
11. Wilson AG, di Giovine FS, Blakemore AIF, et al. Single base polymorphism in the human tumor necrosis factor-alpha gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353.
12. Waterer GW, Quasney MW, Cantor RM, et al. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am J Respir Crit Care Med 2001;163:1599-1604.
13. Kroeger KM, Steer JH, Joyce DA, et al. Effects of stimulus and cell type on the expression of the-308 tumour necrosis factor promoter polymorphism. Cytokine 2000;12:110-119.
14. Louis E, Franchimont D, Piron A, et al. Tumor necrosis factor gene polymorphism influences TNF-α production in LPS-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998;113:401-406.
15. Hajeer AH, Hutchinson IV. Influence of TNF alpha gene polymorphisms on TNF alpha production and disease. Hum Immunol 2001;62:1191-1199.
16. Barber AE, Coyle SM, Marano MA, et al. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 1993;150:1999-2006.
17. Van der Poll T, Coyle SM, Barbosa K, et al. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin-10 production during human endotoxemia. J Clin Invest 1996;97:713-719.
18. Fijen JW, Tulleken JE, Hepkema BG, et al. The influence of the tumor necrosis factor-α and interleukin-10 gene promoter polymorphism on the inflammatory response in experimental human endotoxemia. Clin Infect Dis 2001;33:1601-1603.
19. Knight JC, Udalova I, Hill AV, et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999;22:145-150.
20. Pellegrini JD, Puyana JC, Lapchak PH, et al. A membrane TNF-α/TNFR ratio correlates to MODS score and mortality. Shock 1996;6:389-396.
21. Calvano SE, Van der Poll T, Coyle SM, et al. Monocyte tumor necrosis factor receptor levels as a predictor of risk in human sepsis. Arch Surg 1996;131: 434-437.
22. Agnese DM, Calvano JE, Hahm SJ, et al. Human Toll-like receptor 4 (hTLR4) mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 2002;186: 1522-1525.
23. Lorenz E, Mira JP, Frees KL, et al. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002;162: 1028-1032.